Clinical Trial Update: A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of ixazomib in adults with advanced nonhematologic malignancies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonhematologic Malignancies

Drugs mentioned

• ixazomib (ixazomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Non-hematologic Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2019-09-09